Prokaryotic expression and identification of scavenger receptor B2.

There is still no effective clinical antiviral drug against human enterovirus 71 (EV71) infection, which causes hand, foot and mouth disease (HFMD) in children. Scavenger receptor class B member 2 (SCARB2) is an important receptor of EV71 as it plays a vital role in the early steps of viral infection. In this study, recombinant SCARB2 protein was expressed and purified in a prokaryotic expression system, and was identified by western blot with a monoclonal antibody and mass spectrometry analysis. Detection of the sera from mice immunized with the recombinant SCARB2 protein using ELISA and western blot showed good immunogenicity of the recombinant protein. Furthermore, in the neutralization test cytopathic effect was significantly decreased when EV71 was incubated with the immune sera before infection. In summary, the SCARB2 protein was expressed successfully, and the immune sera showed obvious antiviral effect against EV71. This study provides useful information about the interaction mechanism between SCARB2 and EV71, and is also helpful for further clinical treatment research of HFMD.

[1]  S. Eskendirova,et al.  Expression, purification and immunochemical characterization of recombinant OMP28 protein of Brucella species , 2016, Open veterinary journal.

[2]  G. Kaur,et al.  Phylogenetic analysis of VP2 gene of canine parvovirus and comparison with Indian and world isolates. , 2016, Acta virologica.

[3]  Y. Poovorawan,et al.  Unusual skin manifestation of hand, foot and mouth disease associated with coxsackievirus A6: cases report , 2015, SpringerPlus.

[4]  Yingying Ding,et al.  Characterization of the antibody response against EV71 capsid proteins in Chinese individuals by NEIBM-ELISA , 2015, Scientific Reports.

[5]  Chao Liu,et al.  [Expression of EV71-VP1, PSGL-1 and SCARB2 in Tissues of Infants with Brain Stem Encephalitis]. , 2015, Fa yi xue za zhi.

[6]  Qinjian Zhao,et al.  In Vivo Time-Related Evaluation of a Therapeutic Neutralization Monoclonal Antibody against Lethal Enterovirus 71 Infection in a Mouse Model , 2014, PloS one.

[7]  Cécile Viboud,et al.  Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. , 2014, The Lancet. Infectious diseases.

[8]  P. Tien,et al.  Cell Surface Vimentin Is an Attachment Receptor for Enterovirus 71 , 2014, Journal of Virology.

[9]  Jing-Yi Lin,et al.  Cell and tissue tropism of enterovirus 71 and other enteroviruses infections , 2014, Journal of Biomedical Science.

[10]  Hsiu-Fen Lee,et al.  Enterovirus 71 Infection–Associated Acute Flaccid Paralysis , 2014, Journal of child neurology.

[11]  Nilendu Sarma.  Hand, foot, and mouth disease: current scenario and Indian perspective. , 2013, Indian journal of dermatology, venereology and leprology.

[12]  J. Kwang,et al.  Identification and characterization of a monoclonal antibody recognizing the linear epitope RVADVI on VP1 protein of enterovirus 71 , 2012, Journal of medical virology.

[13]  H. Pourianfar,et al.  A Colorimetric-Based Accurate Method for the Determination of Enterovirus 71 Titer , 2012, Indian Journal of Virology.

[14]  Yue Zhang,et al.  Clinicopathologic features and molecular analysis of enterovirus 71 infection: Report of an autopsy case from the epidemic of hand, foot and mouth disease in China , 2012, Pathology international.

[15]  K. Fujii,et al.  Human SCARB2-Dependent Infection by Coxsackievirus A7, A14, and A16 and Enterovirus 71 , 2012, Journal of Virology.

[16]  K. Fujii,et al.  Scavenger Receptor B2 as a Receptor for Hand, Foot, and Mouth Disease and Severe Neurological Diseases , 2012, Front. Microbio..

[17]  Wenhui Li,et al.  Molecular Determinants of Enterovirus 71 Viral Entry , 2012, The Journal of Biological Chemistry.

[18]  S. Koike,et al.  Identification of a Human SCARB2 Region That Is Important for Enterovirus 71 Binding and Infection , 2011, Journal of Virology.

[19]  Y. Poovorawan,et al.  Clinical and molecular characterization of hand-foot-and-mouth disease in Thailand, 2008-2009. , 2010, Japanese journal of infectious diseases.

[20]  P. Saftig,et al.  Disease-causing mutations within the lysosomal integral membrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand beta-glucocerebrosidase. , 2010, Human molecular genetics.

[21]  Kuender D Yang,et al.  Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells , 2009, Virology Journal.

[22]  S. Koike,et al.  Scavenger receptor B2 is a cellular receptor for enterovirus 71 , 2009, Nature Medicine.

[23]  H-S Liu,et al.  Enterovirus 71‐induced autophagy detected in vitro and in vivo promotes viral replication , 2009, Journal of medical virology.

[24]  F. Allerberger,et al.  Epidemiology of enterovirus types causing neurological disease in Austria 1999–2007: Detection of clusters of echovirus 30 and enterovirus 71 and analysis of prevalent genotypes , 2009, Journal of medical virology.

[25]  N. Tien,et al.  Epidemiologic and Virologic Investigation of Hand, Foot, and Mouth Disease, Southern Vietnam, 2005 , 2007, Emerging infectious diseases.

[26]  P. Saftig,et al.  A role for the lysosomal membrane protein LGP85 in the biogenesis and maintenance of endosomal and lysosomal morphology , 2002, Journal of Cell Science.

[27]  J. Hartwig,et al.  P-Selectin Glycoprotein Ligand 1 (Psgl-1) Is Expressed on Platelets and Can Mediate Platelet–Endothelial Interactions in Vivo , 2000, The Journal of experimental medicine.

[28]  T. Yeh,et al.  Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  S. Subharngkasen.  Foot-and-mouth disease in Thailand. , 1969, Bulletin - Office international des epizooties.

[30]  K. Yusoff,et al.  Immunogenicity of a truncated enterovirus 71 VP1 protein fused to a Newcastle disease virus nucleocapsid protein fragment in mice. , 2011, Acta virologica.